The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: Effect is absent in p53-inactive cells

Robert H Weiss, Collette J. Randour

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The cyclin-dependent kinase inhibitors (CKI) interact with cyclin-cdk complexes to arrest mitogen-stimulated transit through the cell cycle, but we and others have recently shown that these molecules can exert permissive effects on cell cycle transit as well. The p53 protein induces transcription of the p21(Waf1/Cip1) gene, but whether p53 has any effect on the stimulatory versus inhibitory state of p21(Waf1/Cip1) toward cell growth is not known. The focus of the current study was to examine the effect of p21(Waf1/Cip1) inhibition on growth in cells which possess an inactive p53 protein. We found that there was significant and specific inhibition of p21(Waf1/Cip1) protein transcription in human squamous carcinoma A431 cells after transfection of an antisense p21(Waf1/Cip1) oligodeoxynucleotide, yet there was no significant growth inhibition in these cells after stimulation with 10% serum or with PDGF-BB, in contrast to what was observed in vascular smooth muscle (VSM) cells. Furthermore, there was no attenuation of either cyclinD/cdk4 association or of Rb hyperphosphorylation after antisense p21(Waf1/Cip1) oligodeoxynucleotide transfection, suggesting that an alternate pathway exists to allow association and phosphorylation of these cell cycle components in the absence (or with lower levels) of p21(Waf1/Cip1). Thus, the permissive effect of p21(Waf1/Cip1) toward growth is dependent on cell type, and active p53 is likely required for this effect. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)413-418
Number of pages6
JournalCellular Signalling
Volume12
Issue number6
DOIs
StatePublished - Jun 2000

Fingerprint

Cell Cycle
Oligodeoxyribonucleotides
DNA
Growth
Transfection
Proteins
Cyclins
Cyclin-Dependent Kinases
p53 Genes
Cellular Structures
Vascular Smooth Muscle
Mitogens
Smooth Muscle Myocytes
Squamous Cell Carcinoma
Phosphorylation
Serum
platelet-derived growth factor BB

Keywords

  • Cyclin, Cyclin kinase
  • p21(Waf1/Cip1)
  • p53
  • Proliferation
  • Rb

ASJC Scopus subject areas

  • Cell Biology

Cite this

The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type : Effect is absent in p53-inactive cells. / Weiss, Robert H; Randour, Collette J.

In: Cellular Signalling, Vol. 12, No. 6, 06.2000, p. 413-418.

Research output: Contribution to journalArticle

@article{ea81b9fb93bc4a7fab404ee93427f8c8,
title = "The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: Effect is absent in p53-inactive cells",
abstract = "The cyclin-dependent kinase inhibitors (CKI) interact with cyclin-cdk complexes to arrest mitogen-stimulated transit through the cell cycle, but we and others have recently shown that these molecules can exert permissive effects on cell cycle transit as well. The p53 protein induces transcription of the p21(Waf1/Cip1) gene, but whether p53 has any effect on the stimulatory versus inhibitory state of p21(Waf1/Cip1) toward cell growth is not known. The focus of the current study was to examine the effect of p21(Waf1/Cip1) inhibition on growth in cells which possess an inactive p53 protein. We found that there was significant and specific inhibition of p21(Waf1/Cip1) protein transcription in human squamous carcinoma A431 cells after transfection of an antisense p21(Waf1/Cip1) oligodeoxynucleotide, yet there was no significant growth inhibition in these cells after stimulation with 10{\%} serum or with PDGF-BB, in contrast to what was observed in vascular smooth muscle (VSM) cells. Furthermore, there was no attenuation of either cyclinD/cdk4 association or of Rb hyperphosphorylation after antisense p21(Waf1/Cip1) oligodeoxynucleotide transfection, suggesting that an alternate pathway exists to allow association and phosphorylation of these cell cycle components in the absence (or with lower levels) of p21(Waf1/Cip1). Thus, the permissive effect of p21(Waf1/Cip1) toward growth is dependent on cell type, and active p53 is likely required for this effect. Copyright (C) 2000 Elsevier Science Inc.",
keywords = "Cyclin, Cyclin kinase, p21(Waf1/Cip1), p53, Proliferation, Rb",
author = "Weiss, {Robert H} and Randour, {Collette J.}",
year = "2000",
month = "6",
doi = "10.1016/S0898-6568(00)00081-4",
language = "English (US)",
volume = "12",
pages = "413--418",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type

T2 - Effect is absent in p53-inactive cells

AU - Weiss, Robert H

AU - Randour, Collette J.

PY - 2000/6

Y1 - 2000/6

N2 - The cyclin-dependent kinase inhibitors (CKI) interact with cyclin-cdk complexes to arrest mitogen-stimulated transit through the cell cycle, but we and others have recently shown that these molecules can exert permissive effects on cell cycle transit as well. The p53 protein induces transcription of the p21(Waf1/Cip1) gene, but whether p53 has any effect on the stimulatory versus inhibitory state of p21(Waf1/Cip1) toward cell growth is not known. The focus of the current study was to examine the effect of p21(Waf1/Cip1) inhibition on growth in cells which possess an inactive p53 protein. We found that there was significant and specific inhibition of p21(Waf1/Cip1) protein transcription in human squamous carcinoma A431 cells after transfection of an antisense p21(Waf1/Cip1) oligodeoxynucleotide, yet there was no significant growth inhibition in these cells after stimulation with 10% serum or with PDGF-BB, in contrast to what was observed in vascular smooth muscle (VSM) cells. Furthermore, there was no attenuation of either cyclinD/cdk4 association or of Rb hyperphosphorylation after antisense p21(Waf1/Cip1) oligodeoxynucleotide transfection, suggesting that an alternate pathway exists to allow association and phosphorylation of these cell cycle components in the absence (or with lower levels) of p21(Waf1/Cip1). Thus, the permissive effect of p21(Waf1/Cip1) toward growth is dependent on cell type, and active p53 is likely required for this effect. Copyright (C) 2000 Elsevier Science Inc.

AB - The cyclin-dependent kinase inhibitors (CKI) interact with cyclin-cdk complexes to arrest mitogen-stimulated transit through the cell cycle, but we and others have recently shown that these molecules can exert permissive effects on cell cycle transit as well. The p53 protein induces transcription of the p21(Waf1/Cip1) gene, but whether p53 has any effect on the stimulatory versus inhibitory state of p21(Waf1/Cip1) toward cell growth is not known. The focus of the current study was to examine the effect of p21(Waf1/Cip1) inhibition on growth in cells which possess an inactive p53 protein. We found that there was significant and specific inhibition of p21(Waf1/Cip1) protein transcription in human squamous carcinoma A431 cells after transfection of an antisense p21(Waf1/Cip1) oligodeoxynucleotide, yet there was no significant growth inhibition in these cells after stimulation with 10% serum or with PDGF-BB, in contrast to what was observed in vascular smooth muscle (VSM) cells. Furthermore, there was no attenuation of either cyclinD/cdk4 association or of Rb hyperphosphorylation after antisense p21(Waf1/Cip1) oligodeoxynucleotide transfection, suggesting that an alternate pathway exists to allow association and phosphorylation of these cell cycle components in the absence (or with lower levels) of p21(Waf1/Cip1). Thus, the permissive effect of p21(Waf1/Cip1) toward growth is dependent on cell type, and active p53 is likely required for this effect. Copyright (C) 2000 Elsevier Science Inc.

KW - Cyclin, Cyclin kinase

KW - p21(Waf1/Cip1)

KW - p53

KW - Proliferation

KW - Rb

UR - http://www.scopus.com/inward/record.url?scp=0034046954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034046954&partnerID=8YFLogxK

U2 - 10.1016/S0898-6568(00)00081-4

DO - 10.1016/S0898-6568(00)00081-4

M3 - Article

C2 - 10889470

AN - SCOPUS:0034046954

VL - 12

SP - 413

EP - 418

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 6

ER -